> top > docs > PubMed:26684240 > annotations

PubMed:26684240 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
10971 22-26 GeneOrGeneProduct denotes BRAF NCBIGene:673
10972 27-32 SequenceVariant denotes V600E DBSNP:rs113488022
10973 45-89 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors MESH:C535650
10974 111-155 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors MESH:C535650
10975 157-165 DiseaseOrPhenotypicFeature denotes GEP-NETs MESH:C535650
10976 334-342 DiseaseOrPhenotypicFeature denotes GEP-NETs MESH:C535650
10977 348-356 OrganismTaxon denotes patients NCBITaxon:9606
10978 433-442 ChemicalEntity denotes pazopanib MESH:C516667
10979 536-550 DiseaseOrPhenotypicFeature denotes intestine NETs MESH:D007414
10980 652-660 DiseaseOrPhenotypicFeature denotes GEP-NETs MESH:C535650
10981 702-708 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
10982 733-737 GeneOrGeneProduct denotes TP53 NCBIGene:7157
10983 739-744 GeneOrGeneProduct denotes CNBD1 NCBIGene:168975
10984 746-749 GeneOrGeneProduct denotes RB1 NCBIGene:5925
10985 751-754 GeneOrGeneProduct denotes APC NCBIGene:324
10986 756-760 GeneOrGeneProduct denotes BCOR NCBIGene:54880
10987 762-766 GeneOrGeneProduct denotes BRAF NCBIGene:673
10988 768-774 GeneOrGeneProduct denotes CTNNB1 NCBIGene:1499
10989 776-780 GeneOrGeneProduct denotes EGFR NCBIGene:1956
10990 782-787 GeneOrGeneProduct denotes EP300 NCBIGene:2033
10991 789-794 GeneOrGeneProduct denotes ERBB3 NCBIGene:2065
10992 796-801 GeneOrGeneProduct denotes KDM6A NCBIGene:7403
10993 803-807 GeneOrGeneProduct denotes KRAS NCBIGene:3845
10994 809-812 GeneOrGeneProduct denotes MGA NCBIGene:23269
10995 814-818 GeneOrGeneProduct denotes MLL3 NCBIGene:58508
10996 820-824 GeneOrGeneProduct denotes PTEN NCBIGene:5728
10997 826-831 GeneOrGeneProduct denotes RASA1 NCBIGene:5921
10998 833-840 GeneOrGeneProduct denotes SMARCB1 NCBIGene:6598
10999 842-846 GeneOrGeneProduct denotes SPEN NCBIGene:23013
11000 848-855 GeneOrGeneProduct denotes TBC1D12 NCBIGene:23232
11001 861-864 GeneOrGeneProduct denotes VHL NCBIGene:7428
11002 866-870 GeneOrGeneProduct denotes TP53 NCBIGene:7157
11003 919-924 GeneOrGeneProduct denotes CNBD1 NCBIGene:168975
11004 929-932 GeneOrGeneProduct denotes RB1 NCBIGene:5925
11005 979-986 DiseaseOrPhenotypicFeature denotes GEP-NET MESH:C535650
11006 987-995 OrganismTaxon denotes patients NCBITaxon:9606
11007 1001-1005 GeneOrGeneProduct denotes TP53 NCBIGene:7157
11008 1062-1088 DiseaseOrPhenotypicFeature denotes intestinal grade (G) 1 NET MESH:D007414
11009 1089-1096 OrganismTaxon denotes patient NCBITaxon:9606
11010 1102-1106 GeneOrGeneProduct denotes BRAF NCBIGene:673
11011 1107-1112 SequenceVariant denotes V600E DBSNP:rs113488022
11012 1147-1156 ChemicalEntity denotes pazopanib MESH:C516667
11013 1177-1181 GeneOrGeneProduct denotes BRAF NCBIGene:673
11014 1182-1187 SequenceVariant denotes V600E DBSNP:rs113488022
11015 1192-1195 DiseaseOrPhenotypicFeature denotes NET MESH:D018358
11016 1219-1223 DiseaseOrPhenotypicFeature denotes NETs MESH:D018358
11017 1240-1244 GeneOrGeneProduct denotes BRAF NCBIGene:673
11018 1245-1250 SequenceVariant denotes G593S p.G593S
11019 1255-1258 DiseaseOrPhenotypicFeature denotes NET MESH:D018358
11020 1331-1339 DiseaseOrPhenotypicFeature denotes GEP-NETs MESH:C535650
11021 1487-1492 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
11022 1553-1557 GeneOrGeneProduct denotes BRAF NCBIGene:673
11023 1558-1563 SequenceVariant denotes V600E DBSNP:rs113488022
11024 1610-1619 ChemicalEntity denotes pazopanib MESH:C516667
11025 1681-1689 DiseaseOrPhenotypicFeature denotes GEP-NETs MESH:C535650
11026 1690-1698 OrganismTaxon denotes patients NCBITaxon:9606

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-90 Sentence denotes Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
T2 91-285 Sentence denotes Genomic profiles of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are still insufficiently understood, and the genetic alterations associated with drug responses have not been studied.
T3 286-560 Sentence denotes Here, we performed whole exome sequencing of 12 GEP-NETs from patients enrolled in a nonrandomized, open-labeled, single-center phase II study for pazopanib, and integrated our results with previously published results on pancreas (n = 12) and small intestine NETs (n = 50).
T4 561-642 Sentence denotes The mean numbers of somatic mutations in each case varied widely from 20 to 4682.
T5 643-865 Sentence denotes Among 12 GEP-NETs, eight showed mutations of more than one cancer-related gene, including TP53, CNBD1, RB1, APC, BCOR, BRAF, CTNNB1, EGFR, EP300, ERBB3, KDM6A, KRAS, MGA, MLL3, PTEN, RASA1, SMARCB1, SPEN, TBC1D12, and VHL.
T6 866-972 Sentence denotes TP53 was recurrently mutated in three cases, whereas CNBD1 and RB1 mutations were identified in two cases.
T7 973-1167 Sentence denotes Three GEP-NET patients with TP53 mutations demonstrated a durable response and one small intestinal grade (G) 1 NET patient with BRAF V600E mutation showed progression after pazopanib treatment.
T8 1168-1482 Sentence denotes We found BRAF V600E (G1 NET from rectum and two G3 NETs from colon) and BRAF G593S (G2 NET from pancreas) missense mutations (9.1%) in an independent cohort of 44 GEP-NETs from the rectum (n = 26), colon (n = 7), pancreas (n = 4), small intestine (n = 3), stomach (n = 3) and appendix (n = 1) by Sanger sequencing.
T9 1483-1537 Sentence denotes All tumor specimens were obtained before chemotherapy.
T10 1538-1699 Sentence denotes In conclusion, BRAF V600E mutation is likely to result in resistance to pazopanib but may be a potentianally actionable mutation in metastatic GEP-NETs patients.

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 702-708 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 27-32 SequenceVariant denotes V600E
T2 1107-1112 SequenceVariant denotes V600E
T3 1182-1187 SequenceVariant denotes V600E
T4 1245-1250 SequenceVariant denotes G593S
T5 1558-1563 SequenceVariant denotes V600E

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 22-26 GeneOrGeneProduct denotes BRAF
T2 530-535 GeneOrGeneProduct denotes small
T3 733-737 GeneOrGeneProduct denotes TP53
T4 739-744 GeneOrGeneProduct denotes CNBD1
T5 746-749 GeneOrGeneProduct denotes RB1
T6 756-760 GeneOrGeneProduct denotes BCOR
T7 762-766 GeneOrGeneProduct denotes BRAF
T8 768-774 GeneOrGeneProduct denotes CTNNB1
T9 776-780 GeneOrGeneProduct denotes EGFR
T10 782-787 GeneOrGeneProduct denotes EP300
T11 789-794 GeneOrGeneProduct denotes ERBB3
T12 796-801 GeneOrGeneProduct denotes KDM6A
T13 803-807 GeneOrGeneProduct denotes KRAS
T14 814-818 GeneOrGeneProduct denotes MLL3
T15 820-824 GeneOrGeneProduct denotes PTEN
T16 826-831 GeneOrGeneProduct denotes RASA1
T17 833-840 GeneOrGeneProduct denotes SMARCB1
T18 842-846 GeneOrGeneProduct denotes SPEN
T19 848-855 GeneOrGeneProduct denotes TBC1D12
T20 866-870 GeneOrGeneProduct denotes TP53
T21 919-924 GeneOrGeneProduct denotes CNBD1
T22 929-932 GeneOrGeneProduct denotes RB1
T23 983-986 GeneOrGeneProduct denotes NET
T24 1001-1005 GeneOrGeneProduct denotes TP53
T25 1056-1061 GeneOrGeneProduct denotes small
T26 1062-1072 GeneOrGeneProduct denotes intestinal
T27 1085-1088 GeneOrGeneProduct denotes NET
T28 1102-1106 GeneOrGeneProduct denotes BRAF
T29 1177-1181 GeneOrGeneProduct denotes BRAF
T30 1192-1195 GeneOrGeneProduct denotes NET
T31 1240-1244 GeneOrGeneProduct denotes BRAF
T32 1255-1258 GeneOrGeneProduct denotes NET
T33 1399-1404 GeneOrGeneProduct denotes small
T34 1553-1557 GeneOrGeneProduct denotes BRAF

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 22-26 GeneOrGeneProduct denotes BRAF
T2 33-41 GeneOrGeneProduct denotes mutation
T3 83-89 GeneOrGeneProduct denotes tumors
T4 149-155 GeneOrGeneProduct denotes tumors
T5 161-165 GeneOrGeneProduct denotes NETs
T6 311-316 GeneOrGeneProduct denotes exome
T7 338-342 GeneOrGeneProduct denotes NETs
T8 366-370 GeneOrGeneProduct denotes in a
T9 386-390 GeneOrGeneProduct denotes open
T10 420-422 GeneOrGeneProduct denotes II
T11 518-524 GeneOrGeneProduct denotes n = 12
T12 530-535 GeneOrGeneProduct denotes small
T13 536-545 GeneOrGeneProduct denotes intestine
T14 546-550 GeneOrGeneProduct denotes NETs
T15 552-558 GeneOrGeneProduct denotes n = 50
T16 589-598 GeneOrGeneProduct denotes mutations
T17 607-611 GeneOrGeneProduct denotes case
T18 612-618 GeneOrGeneProduct denotes varied
T19 656-660 GeneOrGeneProduct denotes NETs
T20 675-684 GeneOrGeneProduct denotes mutations
T21 733-737 GeneOrGeneProduct denotes TP53
T22 739-744 GeneOrGeneProduct denotes CNBD1
T23 746-749 GeneOrGeneProduct denotes RB1
T24 751-754 GeneOrGeneProduct denotes APC
T25 756-760 GeneOrGeneProduct denotes BCOR
T26 762-766 GeneOrGeneProduct denotes BRAF
T27 768-774 GeneOrGeneProduct denotes CTNNB1
T28 776-780 GeneOrGeneProduct denotes EGFR
T29 782-787 GeneOrGeneProduct denotes EP300
T30 789-794 GeneOrGeneProduct denotes ERBB3
T31 796-801 GeneOrGeneProduct denotes KDM6A
T32 803-807 GeneOrGeneProduct denotes KRAS
T33 814-818 GeneOrGeneProduct denotes MLL3
T34 820-824 GeneOrGeneProduct denotes PTEN
T35 826-831 GeneOrGeneProduct denotes RASA1
T36 833-840 GeneOrGeneProduct denotes SMARCB1
T37 842-846 GeneOrGeneProduct denotes SPEN
T38 848-855 GeneOrGeneProduct denotes TBC1D12
T39 866-870 GeneOrGeneProduct denotes TP53
T40 887-894 GeneOrGeneProduct denotes mutated
T41 904-909 GeneOrGeneProduct denotes cases
T42 919-924 GeneOrGeneProduct denotes CNBD1
T43 929-932 GeneOrGeneProduct denotes RB1
T44 933-942 GeneOrGeneProduct denotes mutations
T45 966-971 GeneOrGeneProduct denotes cases
T46 983-986 GeneOrGeneProduct denotes NET
T47 1001-1005 GeneOrGeneProduct denotes TP53
T48 1006-1015 GeneOrGeneProduct denotes mutations
T49 1056-1061 GeneOrGeneProduct denotes small
T50 1062-1072 GeneOrGeneProduct denotes intestinal
T51 1085-1088 GeneOrGeneProduct denotes NET
T52 1102-1106 GeneOrGeneProduct denotes BRAF
T53 1113-1121 GeneOrGeneProduct denotes mutation
T54 1177-1181 GeneOrGeneProduct denotes BRAF
T55 1192-1195 GeneOrGeneProduct denotes NET
T56 1216-1218 GeneOrGeneProduct denotes G3
T57 1219-1223 GeneOrGeneProduct denotes NETs
T58 1240-1244 GeneOrGeneProduct denotes BRAF
T59 1255-1258 GeneOrGeneProduct denotes NET
T60 1274-1282 GeneOrGeneProduct denotes missense
T61 1283-1292 GeneOrGeneProduct denotes mutations
T62 1335-1339 GeneOrGeneProduct denotes NETs
T63 1357-1363 GeneOrGeneProduct denotes n = 26
T64 1399-1404 GeneOrGeneProduct denotes small
T65 1405-1414 GeneOrGeneProduct denotes intestine
T66 1483-1486 GeneOrGeneProduct denotes All
T67 1487-1492 GeneOrGeneProduct denotes tumor
T68 1553-1557 GeneOrGeneProduct denotes BRAF
T69 1564-1572 GeneOrGeneProduct denotes mutation
T70 1576-1582 GeneOrGeneProduct denotes likely
T71 1624-1632 GeneOrGeneProduct denotes may be a
T72 1658-1666 GeneOrGeneProduct denotes mutation
T73 1685-1689 GeneOrGeneProduct denotes NETs

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 45-89 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors C535650
T2 111-155 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors C535650
T3 702-708 DiseaseOrPhenotypicFeature denotes cancer D009369
T4 875-886 DiseaseOrPhenotypicFeature denotes recurrently D012008
T5 1487-1492 DiseaseOrPhenotypicFeature denotes tumor D009369

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 22-26 GeneOrGeneProduct denotes BRAF
T2 733-737 GeneOrGeneProduct denotes TP53
T3 739-744 GeneOrGeneProduct denotes CNBD1
T4 746-749 GeneOrGeneProduct denotes RB1
T5 756-760 GeneOrGeneProduct denotes BCOR
T6 762-766 GeneOrGeneProduct denotes BRAF
T7 768-774 GeneOrGeneProduct denotes CTNNB1
T8 776-780 GeneOrGeneProduct denotes EGFR
T9 782-787 GeneOrGeneProduct denotes EP300
T10 789-794 GeneOrGeneProduct denotes ERBB3
T11 796-801 GeneOrGeneProduct denotes KDM6A
T12 803-807 GeneOrGeneProduct denotes KRAS
T13 814-818 GeneOrGeneProduct denotes MLL3
T14 820-824 GeneOrGeneProduct denotes PTEN
T15 826-831 GeneOrGeneProduct denotes RASA1
T16 833-840 GeneOrGeneProduct denotes SMARCB1
T17 842-846 GeneOrGeneProduct denotes SPEN
T18 848-855 GeneOrGeneProduct denotes TBC1D12
T19 866-870 GeneOrGeneProduct denotes TP53
T20 919-924 GeneOrGeneProduct denotes CNBD1
T21 929-932 GeneOrGeneProduct denotes RB1
T22 983-986 GeneOrGeneProduct denotes NET
T23 1001-1005 GeneOrGeneProduct denotes TP53
T24 1085-1088 GeneOrGeneProduct denotes NET
T25 1102-1106 GeneOrGeneProduct denotes BRAF
T26 1177-1181 GeneOrGeneProduct denotes BRAF
T27 1192-1195 GeneOrGeneProduct denotes NET
T28 1240-1244 GeneOrGeneProduct denotes BRAF
T29 1255-1258 GeneOrGeneProduct denotes NET
T30 1553-1557 GeneOrGeneProduct denotes BRAF

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 45-89 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors 0000386
T2 111-155 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors 0000386
T3 508-516 DiseaseOrPhenotypicFeature denotes pancreas 0021040
T4 530-550 DiseaseOrPhenotypicFeature denotes small intestine NETs 0018510
T5 746-749 DiseaseOrPhenotypicFeature denotes RB1 0018160
T6 861-864 DiseaseOrPhenotypicFeature denotes VHL 0008667
T7 929-932 DiseaseOrPhenotypicFeature denotes RB1 0018160
T8 979-986 DiseaseOrPhenotypicFeature denotes GEP-NET 0024503
T9 1264-1272 DiseaseOrPhenotypicFeature denotes pancreas 0021040
T10 1381-1389 DiseaseOrPhenotypicFeature denotes pancreas 0021040
T11 1487-1492 DiseaseOrPhenotypicFeature denotes tumor 0005070

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 45-89 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors C535650
T2 111-155 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors C535650
T3 157-165 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T4 334-342 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T5 536-550 DiseaseOrPhenotypicFeature denotes intestine NETs DISEASE
T6 652-660 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T7 702-708 DiseaseOrPhenotypicFeature denotes cancer D009369
T8 979-986 DiseaseOrPhenotypicFeature denotes GEP-NET DISEASE
T9 1062-1088 DiseaseOrPhenotypicFeature denotes intestinal grade (G) 1 NET DISEASE
T10 1192-1195 DiseaseOrPhenotypicFeature denotes NET DISEASE
T11 1219-1223 DiseaseOrPhenotypicFeature denotes NETs DISEASE
T12 1255-1258 DiseaseOrPhenotypicFeature denotes NET DISEASE
T13 1331-1339 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T14 1487-1492 DiseaseOrPhenotypicFeature denotes tumor D009369
T15 1681-1689 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 45-89 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors C535650
T2 111-155 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors C535650
T3 157-165 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T4 334-342 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T5 536-550 DiseaseOrPhenotypicFeature denotes intestine NETs DISEASE
T6 652-660 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T7 702-708 DiseaseOrPhenotypicFeature denotes cancer D009369
T8 979-986 DiseaseOrPhenotypicFeature denotes GEP-NET DISEASE
T9 1062-1088 DiseaseOrPhenotypicFeature denotes intestinal grade (G) 1 NET DISEASE
T10 1192-1195 DiseaseOrPhenotypicFeature denotes NET DISEASE
T11 1219-1223 DiseaseOrPhenotypicFeature denotes NETs DISEASE
T12 1255-1258 DiseaseOrPhenotypicFeature denotes NET DISEASE
T13 1331-1339 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T14 1487-1492 DiseaseOrPhenotypicFeature denotes tumor D009369
T15 1681-1689 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 433-442 ChemicalEntity denotes pazopanib C516667|http://purl.obolibrary.org/obo/CHEBI_71219
T3 1147-1156 ChemicalEntity denotes pazopanib C516667|http://purl.obolibrary.org/obo/CHEBI_71219
T5 1610-1619 ChemicalEntity denotes pazopanib C516667|http://purl.obolibrary.org/obo/CHEBI_71219

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 348-356 OrganismTaxon denotes patients
T2 987-995 OrganismTaxon denotes patients
T3 1089-1096 OrganismTaxon denotes patient
T4 1690-1698 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T5 1610-1619 ChemicalEntity denotes pazopanib http://purl.obolibrary.org/obo/CHEBI_71219|C516667
T3 1147-1156 ChemicalEntity denotes pazopanib http://purl.obolibrary.org/obo/CHEBI_71219|C516667
T1 433-442 ChemicalEntity denotes pazopanib http://purl.obolibrary.org/obo/CHEBI_71219|C516667
T30 1553-1557 GeneOrGeneProduct denotes BRAF
T29 1255-1258 GeneOrGeneProduct denotes NET
T28 1240-1244 GeneOrGeneProduct denotes BRAF
T27 1192-1195 GeneOrGeneProduct denotes NET
T26 1177-1181 GeneOrGeneProduct denotes BRAF
T25 1102-1106 GeneOrGeneProduct denotes BRAF
T24 1085-1088 GeneOrGeneProduct denotes NET
T23 1001-1005 GeneOrGeneProduct denotes TP53
T22 983-986 GeneOrGeneProduct denotes NET
T21 929-932 GeneOrGeneProduct denotes RB1
T20 919-924 GeneOrGeneProduct denotes CNBD1
T19 866-870 GeneOrGeneProduct denotes TP53
T18 848-855 GeneOrGeneProduct denotes TBC1D12
T17 842-846 GeneOrGeneProduct denotes SPEN
T16 833-840 GeneOrGeneProduct denotes SMARCB1
T15 826-831 GeneOrGeneProduct denotes RASA1
T14 820-824 GeneOrGeneProduct denotes PTEN
T13 814-818 GeneOrGeneProduct denotes MLL3
T12 803-807 GeneOrGeneProduct denotes KRAS
T11 796-801 GeneOrGeneProduct denotes KDM6A
T10 789-794 GeneOrGeneProduct denotes ERBB3
T9 782-787 GeneOrGeneProduct denotes EP300
T8 776-780 GeneOrGeneProduct denotes EGFR
T7 768-774 GeneOrGeneProduct denotes CTNNB1
T6 762-766 GeneOrGeneProduct denotes BRAF
T42858 756-760 GeneOrGeneProduct denotes BCOR
T4 746-749 GeneOrGeneProduct denotes RB1
T59666 739-744 GeneOrGeneProduct denotes CNBD1
T2 733-737 GeneOrGeneProduct denotes TP53
T14026 22-26 GeneOrGeneProduct denotes BRAF
T21549 1681-1689 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T34971 1487-1492 DiseaseOrPhenotypicFeature denotes tumor D009369
T51763 1331-1339 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T89093 1255-1258 DiseaseOrPhenotypicFeature denotes NET DISEASE
T17041 1219-1223 DiseaseOrPhenotypicFeature denotes NETs DISEASE
T54477 1192-1195 DiseaseOrPhenotypicFeature denotes NET DISEASE
T48673 1062-1088 DiseaseOrPhenotypicFeature denotes intestinal grade (G) 1 NET DISEASE
T20286 979-986 DiseaseOrPhenotypicFeature denotes GEP-NET DISEASE
T84367 702-708 DiseaseOrPhenotypicFeature denotes cancer D009369
T64672 652-660 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T20728 536-550 DiseaseOrPhenotypicFeature denotes intestine NETs DISEASE
T93864 334-342 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T82078 157-165 DiseaseOrPhenotypicFeature denotes GEP-NETs DISEASE
T32171 111-155 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors C535650
T65925 45-89 DiseaseOrPhenotypicFeature denotes gastroenteropancreatic neuroendocrine tumors C535650
T14368 1690-1698 OrganismTaxon denotes patients
T57822 1089-1096 OrganismTaxon denotes patient
T87458 987-995 OrganismTaxon denotes patients
T66225 348-356 OrganismTaxon denotes patients
T53888 1558-1563 SequenceVariant denotes V600E
T54782 1245-1250 SequenceVariant denotes G593S
T91746 1182-1187 SequenceVariant denotes V600E
T55890 1107-1112 SequenceVariant denotes V600E
T99552 27-32 SequenceVariant denotes V600E

DisGeNET5_variant_disease

Id Subject Object Predicate Lexical cue
26684240-0#27#32#geners113488022 27-32 geners113488022 denotes V600E
26684240-0#68#89#diseaseC0206754 68-89 diseaseC0206754 denotes neuroendocrine tumors
27#32#geners11348802268#89#diseaseC0206754 26684240-0#27#32#geners113488022 26684240-0#68#89#diseaseC0206754 associated_with V600E,neuroendocrine tumors

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
26684240-0#22#26#gene673 22-26 gene673 denotes BRAF
26684240-0#68#89#diseaseC0206754 68-89 diseaseC0206754 denotes neuroendocrine tumors
22#26#gene67368#89#diseaseC0206754 26684240-0#22#26#gene673 26684240-0#68#89#diseaseC0206754 associated_with BRAF,neuroendocrine tumors